Neuroprotection and Cognitive Function Bussian, T
Tanzilli G, Truscelli G, Arrivi A, et al
Importantly, these symptoms were typically mild to moderate and resolved within 48 weeks for the majority of participants
In the UK, several GLP-1 receptor agonists are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA), each with specific indications: semaglutide (Ozempic for type 2 diabetes, Wegovy for weight management), dulaglutide (Trulicity for type 2 diabetes), and liraglutide (Victoza for type 2 diabetes, Saxenda for weight management)
Users consistently report that seeing a ready-made plan on day one removes the guesswork that makes most people put healthy habits off
All content is provided for informational purposes only and does not constitute medical, clinical, or therapeutic advice